- The CRUSH initiative signals a shift in CMS oversight. It points toward faster fraud detection, tighter supplier oversight and more data-driven claims monitoring.
- DMEPOS is specifically in focus. CMS highlights DMEPOS in the RFI because it has historically been considered a higher-risk category for fraud.
- Billing accuracy and documentation will become even more critical. Expanded monitoring, pre-payment review and supplier verification could increase operational pressure.
- Enrollment and ownership requirements may become more demanding. CMS is evaluating stronger screening measures that could add time and complexity to supplier enrollment and revalidation.
- Providers can prepare now. Strengthening documentation, improving revenue cycle speed and evaluating audit readiness can help organizations adapt to potential changes.
The Centers for Medicare & Medicaid Services (CMS) recently introduced the CRUSH Initiative - Comprehensive Regulations to Uncover Suspicious Healthcare, a federal effort aimed at strengthening oversight of fraud, waste and abuse across Medicare, Medicaid, CHIP and the Health Insurance Marketplace.
In February 2026, CMS issued a Request for Information (RFI) seeking industry feedback before potentially developing formal regulatory changes. Comments are open through March 30, 2026.
For Durable Medical Equipment (DME) and Home Medical Equipment (HME) providers, the CRUSH initiative signals a shift toward faster fraud detection, tighter supplier oversight and more data-driven claims monitoring. These are changes that could impact operations, revenue cycle management and compliance strategies.
Below is a look at what the CRUSH initiative could mean for the industry and what providers can do now to prepare.
What Is the CRUSH Initiative?
The CRUSH initiative reflects CMS’s effort to move away from the traditional “pay and chase” model, recovering improper payments after they occur, toward earlier detection and prevention.
CMS is evaluating several approaches to strengthen program integrity, including:
- Expanded use of data analytics and technology
- Stronger provider enrollment screening
- Faster payment suspensions when fraud is suspected
- Expanded audits and medical record reviews
- Greater monitoring of high-risk services such as DMEPOS
Because DMEPOS has historically been considered a higher-risk category for fraud, the industry is specifically highlighted in the CRUSH RFI.
Why DME/HME Providers Should Pay Attention
While the RFI does not represent a finalized rule, it provides a clear preview of where CMS oversight may be heading.
1) Increased scrutiny on DMEPOS billing
CMS has identified non-participating DMEPOS suppliers billing Medicare Advantage plans as a potential fraud risk and is exploring stronger oversight mechanisms.
Possible outcomes could include:
- Expanded monitoring of DME claims
- Increased pre-payment review
- Additional supplier verification requirements
For providers, this means billing accuracy and documentation will become even more critical.
2) Stricter ownership and enrollment requirements
CMS is evaluating stronger supplier screening measures that could include:
- Expanded fingerprinting and background checks
- Enhanced identity verification
- Potential citizenship or residency requirements for certain ownership interests
Supplier enrollment and revalidation processes could become more detailed and time-intensive.
3) Changes to Medicare Advantage participation
CMS has identified a gap where providers revoked from Traditional Medicare may still bill Medicare Advantage plans.
If implemented, this could affect suppliers that currently:
- Operate primarily within Medicare Advantage networks
- Do not maintain traditional Medicare enrollment.
4) Shorter claim filing deadlines
CMS is considering reducing the Medicare claim filing window from one year to 90–180 days for certain high-risk services, including DMEPOS.
Shorter filing timelines would require faster intake, documentation management, and claim submission processes.
5) Expanded use of AI for billing oversight
CMS is also exploring the use of artificial intelligence and machine learning to review medical records, coding, and billing patterns.
AI-driven oversight could help identify:
- Unusual billing patterns
- Documentation inconsistencies
- Coding discrepancies
This means errors or gaps in documentation could be flagged earlier than in traditional audit models.
What DME/HME Providers Should Do Now
Even though the CRUSH initiative is still in the planning phase, providers can begin preparing for a regulatory environment that emphasizes speed, accuracy and documentation integrity.
Strengthen documentation and billing accuracy
Providers should ensure that:
- Physician documentation is complete
- Coding is accurate and consistent
- Orders and delivery documentation are well maintained
Regular internal reviews can help identify potential vulnerabilities before payers or regulators do.
Improve revenue cycle speed
If claim filing timelines are shortened, organizations will need faster workflows for:
- Intake and order processing
- Documentation collection
- Claim submission
Improving revenue cycle efficiency now can help providers stay ahead of potential changes.
Evaluate compliance and audit readiness
Routine compliance reviews and documentation audits can help ensure billing patterns and records align with Medicare expectations.
Proactive compliance programs will become increasingly important as oversight tools become more sophisticated.
Many providers are already taking a closer look at whether their intake, documentation and billing processes can support faster timelines and increased scrutiny. RCM partners, such as Prochant, often support these efforts by helping providers evaluate and improve revenue cycle workflows and compliance readiness.
